|
|
Cardio-renal disease, CNS, Inflammation, Metabolic disease, Oncology - Plexxikon
Description: Plexxikon has utilized its proprietary discovery platform to successfully develop a portfolio of clinical and preclinical stage programs in a number of therapeutic areas, including cardio-renal disease, CNS, inflammation, metabolic disease and oncology.
Keywords: Plexxikon, discovery and development of novel, small molecule pharmaceuticals, proprietary discovery platform, cardio-renal disease, CNS, inflammation, metabolic disease, oncology
Tags:
scaffolddiscoveryfactory,
plexxikon,
disease,
oncology,
metabolic,
inflammation,
renal,
cns,
cardio,
discovery,
drug,
patient,
scaffold,
based,
ndash,
plx,
melanoma,
metastatic,
dosed,
announces,
trial,
phase,
trials,
treats,
initial,
website,
design,
class,
pivotal,
proprietary,
platform,
news,
press,
clinical,
novel,
small,
development,
pharmaceuticals,
molecule,
kit,
Scaffolddiscoveryfactory.net
Content Revalency:
Title: 100.00%
Description: 33.33%
Keywords: 50.00% | Document size: 12,465 bytes
More info:
Whois -
Trace Route -
RBL Check
| SCAFFOLDDISCOVERYFACTORY.NET - Site Location |
| Country/Flag |
 United States |
| City/Region/Zip Code |
, , |
| Organization |
AT&T Internet Services |
| Internet Service Provider |
AT&T Internet Services |
| Site Response Header |
| Response |
HTTP/1.1 302 Moved Temporarily |
| Server |
Microsoft-IIS/7.0 |
| Date |
Sat, 16 Apr 2011 15:27:53 GMT |
| Content-Type |
text/html; charset=UTF-8 |
| Cookie |
CFTOKEN=41619216;path=/ |
|
